U.S. Tech Hardware Stock News

NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

T. Rowe Price Expands Into Alternative Credit With New OFLEX Fund

T. Rowe Price Group (NasdaqGS:TROW) and affiliate Oak Hill Advisors have launched the OFLEX multi strategy credit interval fund. The OFLEX Fund is designed as an alternative credit strategy investing across public and private credit markets. The interval fund structure targets a broad investor base by offering periodic liquidity alongside exposure to less liquid credit assets. T. Rowe Price Group, trading around $88.8 per share, is expanding beyond its core mutual fund and ETF offerings...
NasdaqGS:SFD
NasdaqGS:SFDFood

Smithfield Foods (SFD) Margin Expansion Challenges Skeptical Earnings Narratives

Smithfield Foods (SFD) has put another quarter on the board for FY 2025, with Q3 revenue of US$3.7 billion, basic EPS of US$0.63 and net income excluding extraordinary items of US$248 million. This sits alongside trailing 12 month basic EPS of US$2.24 on revenue of US$15.3 billion and net income of US$869 million. Over recent quarters the company has seen revenue move from US$3.4 billion in Q2 FY 2024 to US$3.7 billion in Q3 FY 2025, while basic EPS has ranged from US$0.48 to US$0.67 across...
NYSE:TFC
NYSE:TFCBanks

How Investors Are Reacting To Truist Financial (TFC) Balancing Customer Values And Plaid-Powered Open Banking

Earlier in March 2026, Truist Financial disclosed a Heritage Foundation shareholder proposal urging a report on potential misalignment between Truist’s policies, public statements, partnerships and the values of its customer base, while the board recommended voting against it at the April 28, 2026 annual meeting. At the same time, Truist and Plaid announced an expanded open banking data-access agreement aimed at improving secure connectivity, data quality, and fraud prevention for Truist...
NasdaqGM:IESC
NasdaqGM:IESCConstruction

A Look At IES Holdings (IESC) Valuation After Its Recent 8% One Day Share Price Move

Recent share price move IES Holdings (IESC) has drawn fresh attention after a one day gain of about 8%, building on a positive past 3 months despite a weaker month. This move is prompting investors to reassess the current valuation and business mix. See our latest analysis for IES Holdings. Stepping back, the recent 8.0% one day share price return sits within a mixed pattern, with a 30 day share price return of negative 9.2% but a 16.0% year to date share price return and very large multi...
NYSE:RNG
NYSE:RNGSoftware

Assessing RingCentral (RNG) Valuation After A Relief Rally And Diverging Fair Value Signals

Market relief rally lifts RingCentral RingCentral (RNG) moved higher after President Trump’s comments on talks with Iran helped spark a broad risk-on rally in growth stocks, with investors rotating into technology names perceived as higher risk assets. See our latest analysis for RingCentral. Beyond today’s relief rally, RingCentral’s 90 day share price return of 32.15% and year to date gain of 40.05% suggest momentum has picked up. However, the 5 year total shareholder return of an 86.36%...
NYSE:MDT
NYSE:MDTMedical Equipment

Assessing Medtronic’s Valuation After FDA Approval Expands OmniaSecure Defibrillation Lead Use

Medtronic (MDT) is back in focus after securing U.S. FDA approval to expand use of its OmniaSecure defibrillation lead to the heart’s left bundle branch area, widening potential applications in conduction system pacing. See our latest analysis for Medtronic. The FDA approval comes as Medtronic’s share price, now at $87.17, reflects a 1-day share price return of 1.17%, a 30-day share price return of 10% and a year-to-date share price return of 9.25%. The 3-year total shareholder return of...
NYSE:BDX
NYSE:BDXMedical Equipment

Assessing Becton Dickinson (BDX) Valuation After Recent Share Price Weakness And Business Separation Plans

BDX share performance and business snapshot Becton Dickinson (BDX) has drawn attention after a period in which the share price has declined about 16% over the past month and roughly 20% over the past 3 months. This has prompted closer scrutiny from investors. The company operates across several healthcare segments, including Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences, supplying devices and diagnostics used by hospitals, laboratories, and...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

Will BBB Foods' (TBBB) Shift From Profit To 2025 Net Loss Reshape Its Investment Narrative?

In March 2026, BBB Foods Inc. reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of MX$21,972.48 million and a quarterly net loss of MX$1,042.51 million, alongside full-year revenue of MX$78,152.94 million and a full-year net loss of MX$2,839.57 million. While revenue increased year-on-year for both the quarter and full year, the company moved from full-year net income of MX$334.42 million to a substantial net loss, highlighting a sharp reversal in...
NasdaqGS:AEP
NasdaqGS:AEPElectric Utilities

A Look At American Electric Power Company (AEP) Valuation After The Piketon Data Center Infrastructure Plan

Why the Piketon data center project matters for AEP shares American Electric Power Company (AEP) is in focus after AEP Ohio, the U.S. Department of Energy and SB Energy outlined multi billion dollar transmission and digital infrastructure plans tied to a 10 gigawatt data center campus in Piketon, Ohio. See our latest analysis for American Electric Power Company. The Piketon announcement comes after a year where AEP’s recent 1 day share price return of 1.8% contrasts with a 7 day decline of...
NYSE:HUBB
NYSE:HUBBElectrical

Is Stronger Organic Grid Demand And A Moderate Buy Consensus Altering The Investment Case For Hubbell (HUBB)?

In early February 2026, Hubbell reported Q4 2025 results showing revenue growth primarily driven by organic demand for its grid and infrastructure products, and analysts maintained a “Moderate Buy” consensus rating. This combination of strong underlying demand and generally supportive analyst views highlights how central grid and infrastructure exposure has become to Hubbell’s investment case. We’ll now examine how this stronger organic grid demand, highlighted in the Q4 results, may...
NasdaqGS:WFRD
NasdaqGS:WFRDEnergy Services

Is It Too Late To Consider Weatherford International (WFRD) After Its 1-Year 72.7% Surge?

Wondering if Weatherford International at around US$91.55 is still offering value after a strong run, or if most of the upside is already reflected in the price. The stock shows a 5.5% gain over the last 7 days, a 13.2% return year to date, and a 72.7% return over 1 year, set against a 12.3% decline over the past month and a very large 5 year gain that is around 7x. These moves have kept attention on Weatherford International as investors weigh what the current share price implies for future...
NYSE:CF
NYSE:CFChemicals

Is It Too Late To Consider CF Industries (CF) After A 60% One Year Surge?

For investors wondering whether CF Industries Holdings at around US$120 a share still offers value, or if most of the upside is already in the rear-view mirror, this article focuses squarely on what the current price might be giving you. The stock has seen a 23.7% gain over the last 30 days, 50.0% year to date, and 60.1% over 1 year. This naturally raises questions about how much of the story is already priced in and how much risk you are taking on at these levels. Recent news coverage has...
NYSE:SMR
NYSE:SMRElectrical

Assessing NuScale Power (SMR) Valuation After Recent Volatility And A Sharp Discount To Fair Value Estimates

Event driven snapshot of NuScale Power NuScale Power (SMR) is back on many investors’ screens after recent share price volatility, with the stock closing at $11.70 and recent returns ranging from a 2.3% daily gain to a 38.0% 1 year decline. See our latest analysis for NuScale Power. That 2.3% 1 day share price gain comes after a series of weaker periods, with a 30 day share price return of 12.9% and a 1 year total shareholder return decline of 38.0%, even though the 3 year total shareholder...
NYSE:ARCO
NYSE:ARCOHospitality

How Investors Are Reacting To Arcos Dorados (ARCO) Balancing Higher Sales, Lower Q4 Profit And A 2026 Dividend

Arcos Dorados Holdings Inc. recently approved a 2026 cash dividend totaling US$0.28 per share, to be paid in four equal quarterly installments of US$0.07 per share to Class A and Class B shareholders of record on specified dates throughout the year. At the same time, the company reported fourth-quarter 2025 results showing higher revenue but lower quarterly net income, alongside full-year 2025 revenue of US$4.68 billion and net income of US$212.12 million, highlighting a contrast between...
NYSE:BLK
NYSE:BLKCapital Markets

Will BlackRock’s (BLK) Staked Ether ETF and Tokenization Push Change Its Core Investment Narrative?

Earlier this month, BlackRock expanded its digital asset lineup by launching the iShares Staked Ethereum Trust ETF (ETHB), offering spot ether exposure with a staking component and a 0.25% sponsor fee, temporarily reduced to 0.12% on the first US$2.50 billion in assets under management for the first year. Alongside backing Securitize in the NYSE’s new tokenized equity platform and overseeing roughly US$130.00 billion across crypto-related products, BlackRock is deepening its role at the...
NYSE:RDW
NYSE:RDWAerospace & Defense

Will Moog’s METEOR Deal and ELSA Baselining Shift Redwire’s (RDW) National Security Power Role?

Redwire Corporation recently announced a US$12.8 million contract to deliver its Extensible Low-Profile Solar Array (ELSA) wings to Moog Inc., which will integrate them into its METEOR satellite bus for a Low Earth Orbit mission supporting an undisclosed national security customer. Beyond the immediate contract win, Moog’s decision to baseline Redwire’s ELSA wings as a standard METEOR bus component highlights potential for recurring national security and satellite power system demand. Next,...
NYSE:DD
NYSE:DDChemicals

Should DuPont’s (DD) Discretionary Reverse Split Authority Reframe How Investors View Its Earnings Stability Narrative?

DuPont de Nemours, Inc. recently announced it is seeking shareholder approval to amend its Certificate of Incorporation to permit a reverse stock split of its common stock at a ratio between 1-for-2 and 1-for-4, with the final ratio and timing left to the Board’s discretion and the ability to delay or abandon the move. This proposal introduces flexibility for DuPont to adjust its share count and share price structure in the future, which could influence how investors assess its capital...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

A Look At Tempus AI (TEM) Valuation After New Cancer Registry Collaboration And Genomic Profiling Study

Tempus AI (TEM) is back on investors’ radar after two cancer focused updates, a new collaboration on a pediatric acute myeloid leukemia registry, and fresh evidence supporting its genomic profiling capabilities. See our latest analysis for Tempus AI. Despite the positive sentiment around its pediatric leukemia registry and genomic profiling study, Tempus AI’s recent 30 day share price return of 15.81% and year to date share price return of 21.20% point to fading momentum, while the 1 year...
NYSE:SYK
NYSE:SYKMedical Equipment

Stryker Cyberattack Contained As Investors Weigh Operational And Valuation Impact

Stryker (NYSE:SYK) confirmed a cyberattack on its Microsoft environment that temporarily disrupted ordering, manufacturing, and shipping operations. The company reports the incident is now contained and manufacturing is being restored. Stryker states there is no evidence that customer or partner data was compromised. Stryker, trading at $332.59, is dealing with a material operational event that directly affected its core manufacturing and distribution processes. The stock has seen a 12.5%...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

A Look At Open Text (OTEX) Valuation As GenAI Security Gaps Draw Investor Attention

Open Text (NasdaqGS:OTEX) is back in focus after releasing a global GenAI security report with the Ponemon Institute, just ahead of its RSA Conference 2026 presentation featuring senior product and marketing leaders. See our latest analysis for Open Text. Despite the recent focus on GenAI security, Open Text’s 1-day and 7-day share price returns of 2.04% and 3.09% come after a 90-day share price return decline of 30.94% and a 1-year total shareholder return decline of 11.31%. This suggests...
NYSE:FCX
NYSE:FCXMetals and Mining

Freeport-McMoRan (FCX) Is Down 5.2% After $7.5 Billion El Abra Expansion Plan - Has The Bull Case Changed?

Freeport-McMoRan has recently applied for environmental approval for a US$7.50 billion expansion of its El Abra copper mine in Chile, including new concentrator and desalination plants and additional tailings storage, with operations targeted to start in 2033 and significantly lift annual copper output if approved. At the same time, management is highlighting resilient copper demand from electrification and data centers and pointing to supportive government policy in both Chile and the US as...
NYSE:PPL
NYSE:PPLElectric Utilities

Is It Time To Reassess PPL (PPL) After Its Recent Share Price Pullback

Investors may be asking whether PPL at around US$36.90 offers good value today, or if the recent price leaves limited upside. The stock has seen mixed recent returns, with a 4.7% decline over the last 7 days and a 1.4% decline over the last 30 days, while still showing 5.1% year to date and 9.5% over 1 year. Over a longer stretch, PPL has returned 51.5% over 3 years and 52.8% over 5 years, which gives important context for anyone trying to understand how the current price fits into its...
NasdaqGS:COGT
NasdaqGS:COGTBiotechs

Assessing Cogent Biosciences (COGT) Valuation After FDA NDA Acceptance And Rising Institutional Interest

Cogent Biosciences (COGT) is back in focus after the FDA accepted its New Drug Application for bezuclastinib in NonAdvanced Systemic Mastocytosis, setting a December 30, 2026 action date with no review issues flagged. See our latest analysis for Cogent Biosciences. The FDA milestone and mixed institutional trading have come at a time when Cogent’s share price has been volatile, with a 1 day share price return of 6.08% and a 90 day share price return of 11.85%. The 1 year total shareholder...
NYSE:UBER
NYSE:UBERTransportation

Is It Time To Reassess Uber Technologies (UBER) After Recent Share Price Weakness?

Wondering if Uber Technologies at US$75.12 is offering value right now, or if the share price already reflects what you might hope to get from it? The stock has returned 0.6% over the last week and 1.7% over the last month. The year-to-date return sits at a 9.3% decline, and the 1-year return at a 1.8% decline, alongside a very large 3-year gain and a 40.8% return over 5 years. These mixed returns have come as Uber remains a central player in ride hailing and delivery, with ongoing product...